Skip to main content
. 2023 Oct 5;2(9):100641. doi: 10.1016/j.jacadv.2023.100641

Table 2.

Procedural Characteristics and Outcomes

Overall (N = 860) HG-AS (n = 368) NF-LG AS (n = 245) Classical LF-LG AS (n = 74) Paradoxical LF-LG AS (n = 173) P Value
Overall HG vs NF-LG
Follow-up vital status
 Alive 774 (90.0) 345 (93.8) 216 (88.2) 66 (89.2) 147 (84.9)
 Deceased 86 (10.0) 23 (6.2) 29 (11.8) 8 (10.8) 26 (15.1) 0.009 0.001
 Cardiovascular death (% of deceased) 30 (34.9) 8 (34.8) 11 (37.9) 2 (25) 9 (34.6) 0.927 0.815
 Noncardiovascular death (% of deceased) 36 (41.9) 6 (26.1) 12 (41.4) 4 (50) 14 (53.8) 0.25 0.25
 Unknown cause of death (% of deceased) 20 (23.2) 9 (39.1) 6 (20.7) 2 (25) 3 (11.5) 0.147 0.145
 Death during TAVR admission (% of total) 5 (0.6) 0 (0) 4 (1.6) 0 (0) 1 (0.6) 0.0638 0.0139
Prosthetic valve type 0.657 0.581
 Self-expanding 745 (86.6) 313 (85.0) 213 (86.9) 68 (91.9) 151 (87.3)
 Balloon-expandable 108 (12.6) 51 (13.9) 31 (12.7) 5 (6.8) 21 (12.1)
 Mechanically-expanding 7 (0.8) 4 (1.1) 1 (0.4) 1 (1.4) 1 (0.6)
Follow-up echocardiographic parameters
 ≥Moderate prosthetic regurgitation 7 (0.8) 5 (1.4) 1 (0.4) 1 (1.4) 0 (0) 0.316 0.452
 Mean prosthetic gradient (mm Hg) 8.6 ± 4.4 9.9 ± 4.4 7.8 ± 3.4 7.6 ± 3.3 7.4 ± 3.7 <0.001 <0.001
Follow-up events (%)
 Pacemaker implantation within 30 d 116 (13.5) 57 (15.7) 30 (12.9) 8 (11.0) 21 (12.9) 0.604 0.404
 Aortic valve reintervention 2 (0.2) 1 (0.3) 0 (0.0) 1 (1.4) 0 (0.0) 0.173 0.414
 Hemorrhagic stroke 3 (0.4) 3 (0.8) 0 (0.0) 0 (0.0) 0 (0.0) 0.259 0.157
 Ischemic stroke 16 (1.9) 4 (1.1) 8 (3.4) 2 (2.7) 2 (1.2) 0.203 0.0565
 Transient ischemic attack 14 (1.7) 7 (1.9) 6 (2.6) 0 (0.0) 1 (0.6) 0.306 0.645

Values are n (%) or mean ± SD. Death during TAVR admission is included in total number of deaths within the first year.

AS = aortic stenosis; HG = high-gradient; KCCQ = Kansas City Cardiomyopathy Questionnaire; LF-LG = low-flow, low-gradient; NF-LG = normal-flow, low-gradient.